Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chris Probert

Showing results (1-10 of 58) with videos related to

Pageof 6
Sort By:
Therapeutic Advances in Gastroenterology|January 16, 2013
Steroids and 5-aminosalicylic acids in moderate ulcerative colitis: addressing the dilemmaChris Probert
Alimentary Pharmacology & Therapeutics|December 19, 2019
Commentary: vitamin D supplementation in Crohn's diseaseChris Probert
Digestive Diseases (Basel, Switzerland)|June 28, 2014
Future methods for the diagnosis of inflammatory bowel diseaseRaphael Aggio, Chris Probert
Journal of Gastrointestinal and Liver Diseases : JGLD|June 21, 2014
Population-based screening in colorectal cancer - current practice and future developments: faecal biomarkers reviewDavid Sawbridge, Chris Probert
Alimentary Pharmacology & Therapeutics|March 29, 2019
Editorial: metabolomic biomarkers for colorectal adenocarcinoma and in the differentiation between irritable bowel syndrome and ulcerative colitis in clinical remission - confounded by the gut microbiome? Authors' replyAshley Bond, Chris Probert
Inflammatory Bowel Diseases|June 12, 2003
A Crohn's repertoire: T cell receptor gammadeltaTrevor Brooklyn, Chris Probert
Frontline Gastroenterology|August 26, 2017
Managing acute severe ulcerative colitis in the hosptialised settingDavid McClements, Chris Probert
Alimentary Pharmacology & Therapeutics|June 28, 2020
Editorial: peristomal pyoderma gangrenosum-a challenge for patients, healthcare professionals and researchTristan Townsend, Chris Probert
BMJ (Clinical Research Ed.)|July 22, 2006
Diagnosis and treatment of pyoderma gangrenosumTrevor Brooklyn, Giles Dunnill, Chris Probert
Frontline Gastroenterology|August 26, 2017
Biosimilars: what's around the corner?Richard K Russell, Peter Irving, Chris Probert
Pageof 6

Showing results (1-10 of 58) with videos related to

Sort By:
Pageof 6
Therapeutic Advances in Gastroenterology|January 16, 2013
Steroids and 5-aminosalicylic acids in moderate ulcerative colitis: addressing the dilemmaChris Probert
Alimentary Pharmacology & Therapeutics|December 19, 2019
Commentary: vitamin D supplementation in Crohn's diseaseChris Probert
Digestive Diseases (Basel, Switzerland)|June 28, 2014
Future methods for the diagnosis of inflammatory bowel diseaseRaphael Aggio, Chris Probert
Journal of Gastrointestinal and Liver Diseases : JGLD|June 21, 2014
Population-based screening in colorectal cancer - current practice and future developments: faecal biomarkers reviewDavid Sawbridge, Chris Probert
Alimentary Pharmacology & Therapeutics|March 29, 2019
Editorial: metabolomic biomarkers for colorectal adenocarcinoma and in the differentiation between irritable bowel syndrome and ulcerative colitis in clinical remission - confounded by the gut microbiome? Authors' replyAshley Bond, Chris Probert
Inflammatory Bowel Diseases|June 12, 2003
A Crohn's repertoire: T cell receptor gammadeltaTrevor Brooklyn, Chris Probert
Frontline Gastroenterology|August 26, 2017
Managing acute severe ulcerative colitis in the hosptialised settingDavid McClements, Chris Probert
Alimentary Pharmacology & Therapeutics|June 28, 2020
Editorial: peristomal pyoderma gangrenosum-a challenge for patients, healthcare professionals and researchTristan Townsend, Chris Probert
BMJ (Clinical Research Ed.)|July 22, 2006
Diagnosis and treatment of pyoderma gangrenosumTrevor Brooklyn, Giles Dunnill, Chris Probert
Frontline Gastroenterology|August 26, 2017
Biosimilars: what's around the corner?Richard K Russell, Peter Irving, Chris Probert
Pageof 6